Synthetic Biologics, Inc. (NYSE:SYN)

Adeona (AMEX:AEN - News) is a pharmaceutical company developing new medicines for serious central nervous systems diseases.  Our primary strategy is to license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to a valuation inflection point resulting in a significant development and marketing collaboration. We have four drug candidates and one medical food candidate in development. Further information on the company is available at www.adeonapharma.com.

Web site: http://adeonapharma.com

Last updated September 23, 2010


Market Data powered by QuoteMedia. Terms of Use